|
Real-time Estimate
Cboe BZX
15:59:44 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.5787 USD | +21.93% |
|
+9.05% | -99.39% |
| 10-08 | RBC Raises Price Target on Onconetix to $459 From $450, Keeps Outperform Rating | MT |
| 09-24 | SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCONETIX, INC. | Biopharmaceuticals | +18.92% | +9.05% | -99.39% | -99.73% | - | 2.36M |  | | |
- Stock Market
- Stocks
- ONCO Stock
- Charts Onconetix, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
